Collaborative Care In Major Depressive Disorder: Strategies & Resources From Otsuka’s Frameworks In Health & Quality Program

July 27, 2017 - Free Executive Web Briefing Sponsored By Otsuka Pharmaceutical Development & Commercialization, Inc.s Frameworks In Health & Quality Program Presented By: Heidi C. Waters, MBA, PhD, Director of Outcomes Management at Otsuka Pharmaceutical Development & Commercialization, Inc. & Annie Medina, MBA, ACNP-BC, Senior Associate, OPEN MINDS Major Depressive Disorder (MDD) is estimated to affect over 16% of the U.S. population over the course of their lifetime.1 It is often co-occurring with chronic medical conditions like diabetes or cardiovascular disease, as well as with other mental illnesses such as anxiety and substance use disorders . . .